Sana Biotechnology/$SANA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Sana Biotechnology
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
Ticker
$SANA
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
194
ISIN
US7995661045
Website
SANA Metrics
BasicAdvanced
$512M
-
-$0.88
1.75
-
Price and volume
Market cap
$512M
Beta
1.75
52-week high
$8.17
52-week low
$1.26
Average daily volume
3.2M
Financial strength
Current ratio
3.4
Quick ratio
3.158
Long term debt to equity
37.455
Total debt to equity
43.674
Management effectiveness
Return on assets (TTM)
-23.84%
Return on equity (TTM)
-71.44%
Valuation
Price to book
2.45
Price to tangible book (TTM)
55.29
Price to free cash flow (TTM)
-2.392
Growth
Earnings per share change (TTM)
-42.39%
3-year earnings per share growth (CAGR)
-7.82%
What the Analysts think about SANA
Analyst ratings (Buy, Hold, Sell) for Sana Biotechnology stock.
SANA Financial Performance
Revenues and expenses
SANA Earnings Performance
Company profitability
SANA News
AllArticlesVideos
Sana Biotechnology to Present at June 2025 Investor Conferences
GlobeNewsWire·2 days ago
Securities Lawsuit Alert: Sana Biotechnology, Inc. (SANA) - Contact Levi & Korsinsky Before May 20, 2025
Accesswire·1 week ago
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewsWire·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sana Biotechnology stock?
Sana Biotechnology (SANA) has a market cap of $512M as of May 30, 2025.
What is the P/E ratio for Sana Biotechnology stock?
The price to earnings (P/E) ratio for Sana Biotechnology (SANA) stock is 0 as of May 30, 2025.
Does Sana Biotechnology stock pay dividends?
No, Sana Biotechnology (SANA) stock does not pay dividends to its shareholders as of May 30, 2025.
When is the next Sana Biotechnology dividend payment date?
Sana Biotechnology (SANA) stock does not pay dividends to its shareholders.
What is the beta indicator for Sana Biotechnology?
Sana Biotechnology (SANA) has a beta rating of 1.75. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.